Gelteq Ltd (GELS) stock
GELSNasdaqPharmaceutical PreparationsFiscal year ends June 30
$0.27+0.00 (+0.37%)
Close on Nov 18, 2026Market cap $2.89MP/E –Yield –
Gelteq operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
For fiscal 2025 it was -A$5.50M.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | -A$5.50M | – |
| FY2024 | Jun 30, 2024 | -A$2.95M | – |
| FY2023 | Jun 30, 2023 | -A$3.10M | – |
See a number that looks wrong?